Amiodarone pulmonary toxicity presenting as bilateral exudative pleural effusions

Area of Science:

• Pulmonology
• Cardiology
• Toxicology

Background:

• Amiodarone is a widely used antiarrhythmic medication.
• Drug-related side effects are known complications of amiodarone therapy.
• Pulmonary toxicity, such as fibrosing alveolitis, is a recognized adverse effect.

Observation:

• Anecdotal reports suggest possible pleural involvement with amiodarone.
• This report describes an unusual case of amiodarone-induced pulmonary toxicity.
• The patient presented with bilateral exudative pleural effusions and multi-organ toxic involvement.

Findings:

• Amiodarone can manifest as pleural disease, specifically bilateral exudative pleural effusions.
• Pleural reactions are an under-recognized aspect of amiodarone's pulmonary toxicity.
• Literature review confirms amiodarone-associated pleural reactions as a rare but documented phenomenon.

Implications:

• Clinicians should consider amiodarone-induced pleural disease in patients on this medication presenting with unexplained pleural effusions.
• Early recognition and management of amiodarone toxicity are crucial for patient outcomes.
• Further research may elucidate the mechanisms underlying amiodarone-induced pleural reactions.